Johns Hopkins University

Oncology & Cancer

A new microfluidic system could keep tabs on cancer treatment

Found in a patient's blood, circulating tumor cells, or CTCs, have powerful potential to indicate how well a cancer treatment is working and guide treatment decisions. Even so, CTC technologies have not yet been widely implemented ...

Diseases, Conditions, Syndromes

Better data needed to defeat COVID-19 misinformation, experts say

Two experts from the Johns Hopkins Coronavirus Resource Center say the scientific community needs to urgently reform how public health data and preliminary research findings are communicated during future global crises to ...

Neuroscience

Exploring the possibility of a cure for comas

Terry Wallis had been unable to respond to the world since 1984, when the truck he was riding in veered off an Arkansas bridge and crashed, tires up, into the creek bed below. Wallis spent two weeks in a coma, a state of ...

Diseases, Conditions, Syndromes

AI speeds sepsis detection to prevent hundreds of deaths

Patients are 20% less likely to die of sepsis because a new AI system developed at Johns Hopkins University catches symptoms hours earlier than traditional methods, an extensive hospital study demonstrates.

Diseases, Conditions, Syndromes

Omicron subvariants and the changing landscape of COVID-19

Omicron is mutating in giant leaps, with scientists racing to keep up. Its diversity is challenging vaccine efficacy and complicating treatment. But this fall, broad spectrum bivalent vaccines may help mitigate the seemingly ...

Diseases, Conditions, Syndromes

The pandemic has reached a plateau, but for how long?

The U.S. appears to have reached a plateau with the omicron subvariant that's surged this spring, but it's too early to know if positive trends will stick, according to Tom Inglesby, who recently returned to his role directing ...

Immunology

Antibodies point researchers toward broad coronavirus vaccines

Scientists at Johns Hopkins University and Scripps Research have characterized 30 antibodies that recognize a wide range of coronaviruses—successfully blocking not only all the SARS-CoV-2 variants that were tested but also ...

page 10 from 40